123 related articles for article (PubMed ID: 11332905)
1. Human immunodeficiency virus infection in elderly patients.
Butt AA; Dascomb KK; DeSalvo KB; Bazzano L; Kissinger PJ; Szerlip HM
South Med J; 2001 Apr; 94(4):397-400. PubMed ID: 11332905
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus in an aging population, a complication of success.
Kirk JB; Goetz MB
J Am Geriatr Soc; 2009 Nov; 57(11):2129-38. PubMed ID: 19793157
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
4. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
5. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
6. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
Hulgan T; Raffanti S; Kheshti A; Blackwell RB; Rebeiro PF; Barkanic G; Ritz B; Sterling TR
J Infect Dis; 2005 Sep; 192(6):950-7. PubMed ID: 16107946
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations of infection with human immunodeficiency virus among adolescents in Louisiana.
Fuller C; Clark RA; Kissinger P; Abdalian SE
J Adolesc Health; 1996 Jun; 18(6):422-8. PubMed ID: 8803734
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.
Chiao EY; Giordano TP; Richardson P; El-Serag HB
J Clin Oncol; 2008 Jan; 26(3):474-9. PubMed ID: 18202423
[TBL] [Abstract][Full Text] [Related]
9. The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study.
Skiest DJ; Rubinstien E; Carley N; Gioiella L; Lyons R
Am J Med; 1996 Dec; 101(6):605-11. PubMed ID: 9003107
[TBL] [Abstract][Full Text] [Related]
10. WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts.
Teck R; Ascurra O; Gomani P; Manzi M; Pasulani O; Kusamale J; Salaniponi FM; Humblet P; Nunn P; Scano F; Harries AD; Zachariah R
Int J Tuberc Lung Dis; 2005 Mar; 9(3):258-62. PubMed ID: 15786887
[TBL] [Abstract][Full Text] [Related]
11. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2.
Beilke MA; Theall KP; O'Brien M; Clayton JL; Benjamin SM; Winsor EL; Kissinger PJ
Clin Infect Dis; 2004 Jul; 39(2):256-63. PubMed ID: 15307036
[TBL] [Abstract][Full Text] [Related]
13. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
14. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
15. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
16. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events.
Stebbing J; Waters L; Mandalia S; Bower M; Nelson M; Gazzard B
Clin Infect Dis; 2005 Sep; 41(6):906-11. PubMed ID: 16107994
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus.
Massad LS; Silverberg MJ; Springer G; Minkoff H; Hessol N; Palefsky JM; Strickler HD; Levine AM; Sacks HS; Moxley M; Heather Watts D
Am J Obstet Gynecol; 2004 May; 190(5):1241-8. PubMed ID: 15167825
[TBL] [Abstract][Full Text] [Related]
19. HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations.
Williams BG; Korenromp EL; Gouws E; Schmid GP; Auvert B; Dye C
J Infect Dis; 2006 Nov; 194(10):1450-8. PubMed ID: 17054076
[TBL] [Abstract][Full Text] [Related]
20. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
Guo JJ; Jang R; Louder A; Cluxton RJ
Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]